228 related articles for article (PubMed ID: 32203150)
1. ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion.
Steinhaeuser SS; Morera E; Budkova Z; Schepsky A; Wang Q; Rolfsson O; Riedel A; Krueger A; Hilmarsdottir B; Maelandsmo GM; Valdimarsdottir B; Sigurdardottir AK; Agnarsson BA; Jonasson JG; Ingthorsson S; Traustadottir GA; Oskarsson T; Gudjonsson T
Lab Invest; 2020 Jul; 100(7):928-944. PubMed ID: 32203150
[TBL] [Abstract][Full Text] [Related]
2. YKL-40/CHI3L1 facilitates migration and invasion in HER2 overexpressing breast epithelial progenitor cells and generates a niche for capillary-like network formation.
Morera E; Steinhäuser SS; Budkova Z; Ingthorsson S; Kricker J; Krueger A; Traustadottir GA; Gudjonsson T
In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):838-853. PubMed ID: 31482369
[TBL] [Abstract][Full Text] [Related]
3. Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial-Mesenchymal Transition and Responds to Oxidative Stress.
Wang Q; Karvelsson ST; Kotronoulas A; Gudjonsson T; Halldorsson S; Rolfsson O
Mol Cell Proteomics; 2022 Feb; 21(2):100185. PubMed ID: 34923141
[TBL] [Abstract][Full Text] [Related]
4. Melflufen, a peptide-conjugated alkylator, is an efficient anti-neo-plastic drug in breast cancer cell lines.
Schepsky A; Traustadottir GA; Joelsson JP; Ingthorsson S; Kricker J; Bergthorsson JT; Asbjarnarson A; Gudjonsson T; Nupponen N; Slipicevic A; Lehmann F; Gudjonsson T
Cancer Med; 2020 Sep; 9(18):6726-6738. PubMed ID: 32717133
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases.
Gómez-Contreras P; Ramiro-Díaz JM; Sierra A; Stipp C; Domann FE; Weigel RJ; Lal G
Clin Exp Metastasis; 2017 Jan; 34(1):37-49. PubMed ID: 27770373
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.
Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Halabi N; Guerrouahen BS; Rafii S; Rafii A
J Transl Med; 2015 Jan; 13():27. PubMed ID: 25623554
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix protein 1 recruits moesin to facilitate invadopodia formation and breast cancer metastasis.
Wu Q; Chen D; Luo Q; Yang Q; Zhao C; Zhang D; Zeng Y; Huang L; Zhang Z; Qi Z
Cancer Lett; 2018 Nov; 437():44-55. PubMed ID: 30165197
[TBL] [Abstract][Full Text] [Related]
8. ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition.
Chen H; Jia W; Li J
World J Surg Oncol; 2016 Jul; 14(1):195. PubMed ID: 27460906
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of MIIP regulates human breast cancer proliferation, invasion and migration by mediated by IGFBP2.
Du Y; Wang P
Pathol Res Pract; 2019 Jul; 215(7):152440. PubMed ID: 31078343
[TBL] [Abstract][Full Text] [Related]
10. Application of 3D Culture Assays to Study Breast Morphogenesis, Epithelial Plasticity, and Cellular Interactions in an Epithelial Progenitor Cell Line.
Sigurdardottir AK; Hilmarsdottir B; Gudjonsson T; Traustadottir GA
Methods Mol Biol; 2022; 2429():391-403. PubMed ID: 35507176
[TBL] [Abstract][Full Text] [Related]
11. Fluid flow exposure promotes epithelial-to-mesenchymal transition and adhesion of breast cancer cells to endothelial cells.
Fuh KF; Shepherd RD; Withell JS; Kooistra BK; Rinker KD
Breast Cancer Res; 2021 Oct; 23(1):97. PubMed ID: 34641959
[TBL] [Abstract][Full Text] [Related]
12. HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR.
Ingthorsson S; Andersen K; Hilmarsdottir B; Maelandsmo GM; Magnusson MK; Gudjonsson T
Oncogene; 2016 Aug; 35(32):4244-55. PubMed ID: 26686087
[TBL] [Abstract][Full Text] [Related]
13. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
14. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
15. EMT Transition Alters Interstitial Fluid Flow-Induced Signaling in ERBB2-Positive Breast Cancer Cells.
Tchafa AM; Ta M; Reginato MJ; Shieh AC
Mol Cancer Res; 2015 Apr; 13(4):755-64. PubMed ID: 25566992
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling.
Lee KM; Nam K; Oh S; Lim J; Kim YP; Lee JW; Yu JH; Ahn SH; Kim SB; Noh DY; Lee T; Shin I
Breast Cancer Res; 2014 Dec; 16(6):479. PubMed ID: 25499743
[TBL] [Abstract][Full Text] [Related]
17. PYK2 promotes HER2-positive breast cancer invasion.
Al-Juboori SI; Vadakekolathu J; Idri S; Wagner S; Zafeiris D; Pearson JR; Almshayakhchi R; Caraglia M; Desiderio V; Miles AK; Boocock DJ; Ball GR; Regad T
J Exp Clin Cancer Res; 2019 May; 38(1):210. PubMed ID: 31118051
[TBL] [Abstract][Full Text] [Related]
18. ErbB2-enhanced invasiveness of H-Ras MCF10A breast cells requires MMP-13 and uPA upregulation via p38 MAPK signaling.
Yong HY; Kim IY; Kim JS; Moon A
Int J Oncol; 2010 Feb; 36(2):501-7. PubMed ID: 20043086
[TBL] [Abstract][Full Text] [Related]
19. ECM1 regulates tumor metastasis and CSC-like property through stabilization of β-catenin.
Lee KM; Nam K; Oh S; Lim J; Kim RK; Shim D; Choi JH; Lee SJ; Yu JH; Lee JW; Ahn SH; Shin I
Oncogene; 2015 Dec; 34(50):6055-65. PubMed ID: 25746001
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion.
Aceto N; Duss S; MacDonald G; Meyer DS; Roloff TC; Hynes NE; Bentires-Alj M
Breast Cancer Res; 2012 Oct; 14(5):R131. PubMed ID: 23062209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
